Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development

9 Jul 1998

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Research and Treatments
Share to TGF-β signaling in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9671311
DOI: 10.1038/sj.onc.1202161

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma developmentPMID 9671311Read ↗

Mouse model systems to study multistep tumorigenesis.Semantic proximity Read ↗

Transgenic mice and squamous multistage skin carcinogenesis.Semantic proximity Read ↗

Mouse models for multistep tumorigenesisSemantic proximity Read ↗

Biology of TGF-β in knockout and transgenic mouse modelsSemantic proximity Read ↗

The complexities of TGF-β action during mammary and squamous cell carcinogenesis.Semantic proximity Read ↗

Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibitionSemantic proximity Read ↗

Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.Semantic proximity Read ↗

Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progressionSemantic proximity Read ↗

Roles for the type III TGF-β receptor in human cancerSemantic proximity Read ↗

Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination.Semantic proximity Read ↗

Chemically induced skin carcinogenesis: Updates in experimental models (Review)Semantic proximity Read ↗

Mouse models of transforming growth factor β impact in breast development and cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.